Quinones, alkylation reduction

Ouyang, A. Skibo, E. B. Design of a cyclopropyl quinone methide reductive alkylating agent. J. Org. Chem. 1998, 63, 1893-1900. 

The requirement for reduction prior to DNA alkylation and crosslinking was first demonstrated by Iyer and Szybalski in 1964 [29], and can be induced both by chemical reducing agents such as sodium dithionite and thiols in vitro and by various reductive enzymes such as DT-diaphorase (NAD(P)H-quinone oxidoreduc-tase) in vitro and in vivo [47]. Much work to characterize the mechanism of reductive activation and alkylation has been carried out, principally by the Tomasz and Kohn groups, and Figure 11.1 illustrates a generally accepted pathway for mitomycin C [16, 48-50] based on these experiments, which is very similar to the mechanism originally proposed by Iyer and Szybalski [29]. 

Solanesol and other prenyl alcohols are important as metabolites in mulberry and tobacco leaves and in the synthesis of isoprenoid quinones. Hence, Sato and collaborators107 have developed a stereoselective synthesis of all-trans-polyprenol alcohols up to C50. Construction of the requisite skeletons was accomplished by the alkylation of a p-toluenesulphonyl-stabilized carbanion, followed by reductive desulphonylation of the resulting allylic sulphonyl group. This was achieved most efficiently by the use of a large excess of lithium metal in ethylamine (equation (43)), although all reaction conditions led to mixtures. The minor product results from double bond rearrangement. 

The continuing interest in bioreductive alkylation is largely due to the clinical success of mitomycin C and the low reduction potentials observed in many tumors.9 The low reduction potentials favor the quinone to hydroquinone conversion necessary for bioreductive alkylation. Hypoxia due to low blood flow3 and/or the unusually high expression of the quinone two-electron reducing enzyme DT-diaphorase in some histological cancer types10-14 contribute to the tumor s tendency to reduce quinones. 

The bioreductive alkylating agents developed in this laboratory did not afford observable quinone methide species upon quinone reduction and leaving group... 

Top Port Reductive alkylating agent (quinone) in DMSO... 

The UV-Vis spectral detection of an intermediate in the catalytic reductive alkylation reaction provides only circumstantial evidence of the quinone methide species. If the bioreductive alkylating agent has a 13C label at the methide center, then a 13C-NMR could provide chemical shift evidence of the methide intermediate. Although this concept is simple, the synthesis of such 13C-labeled materials may not be trivial. We carried out the synthesis of the 13C-labeled prekinamycin shown in Scheme 7.5 and prepared its quinone methide by catalytic reduction in an N2 glove box. An enriched 13C-NMR spectrum of this reaction mixture was obtained within 100 min of the catalytic reduction (the time of the peak intermediate concentration in Fig. 7.2). This spectrum clearly shows the chemical shift associated with the quinone methide along with those of decomposition products (Fig. 7.3). 

In vivo studies were carried on the aziridinated cyclopent[Z ]indole quinone out before it was discovered that the aziridinyl ring did not participate in DNA alkylation. The results in Fig. 7.22 for the B16 melanoma syngraft model reveal that there was substantial reduction of tumor mass at 3 mg/kg. However, toxicity (animal deaths) became apparent at 5 mg/kg. On the other hand, human lung cancer xenografts in SCID (severe combined immunodeficient) mice were reduced to 50% mass with 3x1 mg/kg doses without any animal deaths. 

The most important conclusion of this research program is that quinone methide O-protonation is required for alkylation to occur. The quinone methide species is often referred to in the literature as an electrophilic species. Actually, the quinone methides obtained from reductive activation possess a slightly electron-rich methide center. There is electron release to the methide center by the hydroxyl, which is balanced by electron... 

Lemus, R. L. Skibo, E. B. Studies of extended quinone methides. Design of reductive alkylating agents based on the quinazoline ring system, j. Org. Chem. 1988, 53, 6099-6105. 

The redox system consists of pyrene or 9,10-phenanthrene quinone as oxidant and an alkyl ester of 3,3, 3"-nitrilopropionic acid as reductant.121 This system deactivates oxidation by bisimidazole when irradiated at 380-550nm, since the quinone is reduced to hydroquinone and thus stabilizing the previously generated dye image.122,123... 

The catalytic cycle of laccase includes several one-electron transfers between a suitable substrate and the copper atoms, with the concomitant reduction of an oxygen molecule to water during the sequential oxidation of four substrate molecules [66]. With this mechanism, laccases generate phenoxy radicals that undergo non-enzymatic reactions [65]. Multiple reactions lead finally to polymerization, alkyl-aryl cleavage, quinone formation, C> -oxidation or demethoxylation of the phenolic reductant [67]. 

The half-wave reduction potentials for a series of annelated 1,4 naphthoquinones (102-106) increase upon alkylation, and decrease as ring size decreases (Table 13). The more cathodic reduction potentials of 2,3-dimethylnaphtho-l,4-qui-none (106, 0.846 V) and l,2,3,4-tetrahydro-9,10-anthroquinone (105,0.854 V) as compared to 1,4-naphthoquinone (0.685 V) are expected from inductive electron donation of alkyl groups. A decrease in reduction potential from 105 to 2,3-cyclobutanaphtho-l,4-quinone (103) (0.695 V) as ring size decreases is observed such that the reduction potential of 103 is only slightly higher than the parent 1,4-naphthoquinone. 

The quinones 7 (R = alkyl) were reductively acetylated with zinc-acetic anhydride giving 8. ... 

In the ESR spectra of some related trimethylsilyl benzoquinone derivatives, as with the ketyls, the spin density in the quinone ring increases for trimethylsilyl substitution and decreases for alkyl substitution, consistent with the electron-accepting ability of the trimethylsilyl group. This ability is also manifested in the reduction potentials of the compounds (65). The ESR data for the trimethylsily ketyls and for the trimethylsilyl benzoquinone anion radicals are summarized in Table IX. 

---